SEC 13F Intelligence

Abacus Fcf Advisors LLC / LLY

Abacus Fcf Advisors LLC’s Eli Lilly & Co Position

Does Abacus Fcf Advisors LLC own Eli Lilly & Co (LLY)? Not currently — the last reported position was 4.1K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2023
Shares
4.1K
% of Portfolio
+1.16%
Quarters Held
10
position exited

Position History LLY

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q1 ’19: $1MQ2 ’19: $1MQ2 ’19Q1 ’22: $3MQ2 ’22: $2MQ2 ’22Q3 ’22: $2MQ4 ’22: $2MQ4 ’22Q1 ’23: $2MQ2 ’23: $2MQ2 ’23Q3 ’23: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20234.1K$2M+1.16%
Q2 20234.2K$2M+0.99%
Q1 20235.6K$2M+1.03%
Q4 20226.1K$2M+1.46%
Q3 20226.2K$2M+1.39%
Q2 20226.7K$2M+1.33%
Q1 202211.5K$3M+1.10%
Q2 20199.4K$1M+0.85%
Q1 201910.4K$1M+1.05%
Q4 201810.0K$1M+1.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abacus Fcf Advisors LLC’s full portfolio or all institutional holders of LLY.